Notice on Convening the 2nd Extraordinary General Meeting in 2026
Securities code: 600513 Securities abbreviation: Lianhuan Pharmaceutical Announcement number: 2026-058
Jiangsu Lianhuan Pharmaceutical Co., Ltd.
Notice on convening the second extraordinary shareholders' meeting in 2026
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
Important content reminder:
Date of shareholders’ meeting: September 22, 2026
The online voting system adopted for this shareholders’ meeting: Shanghai Stock Exchange Shareholders’ Meeting Online Voting System
1. Basic information on convening the meeting
(1) Type and session of shareholders’ meeting
The second extraordinary shareholders' meeting in 2026
(2) Convener of shareholders’ meeting: Board of Directors
(3) Voting method: The voting method used in this shareholders’ meeting is a combination of on-site voting and online voting.
(4) Date, time and place of on-site meeting
Date and time of convening: 14:00 on September 22, 2026
Venue: Lianhuan Pharmaceutical Conference Room, No. 9 Kangkang 1st Road, Yangzhou Bio-Health Industrial Park
(5) Online voting system, start and end dates, and voting time.
Online voting system: Shanghai Stock Exchange Shareholders Meeting online voting system
Online voting starts and ends on September 22, 2026
Until September 22, 2026
Using the Shanghai Stock Exchange's online voting system, the voting time through the trading system voting platform is the trading time period on the day the shareholders' meeting is held, that is, 9:15-9:25, 9:30-11:30, 13:00-15:00; the voting time through the Internet voting platform is 9:15-15:00 on the day the shareholders' meeting is held.
(6) The voting procedures for margin trading, securities lending, refinancing, agreed repurchase business accounts and Shanghai-Hong Kong Stock Connect investors' voting procedures involving margin trading, refinancing business, agreed repurchase business-related accounts and Shanghai-Hong Kong Stock Connect investors shall be implemented in accordance with the "Shanghai Stock Exchange Self-Discipline Supervision Guidelines for Listed Companies No. 1 - Standardized Operations" and other relevant regulations.
(7) Involving public solicitation of shareholder voting rights
None
2. Matters to be considered at the meeting
The resolutions to be reviewed and the types of voting shareholders at this shareholders’ meeting
Voting shareholder type
Serial number Bill name
A-share shareholders
Non-cumulative voting motion
1 "Lianhuan Pharmaceutical's shareholder dividends in the next three years (2026-2028)" √
Proposal for Return Planning》
- The time and disclosure media of each proposal
The above proposal has been reviewed and approved by the company at the 28th extraordinary meeting of the ninth board of directors held on August 27, 2026. The announcement of the meeting resolution has been published in the company's designated disclosure media "Shanghai Securities News", "Securities Times" and the Shanghai Stock Exchange website http://www.sse.com.cn.
Special resolutions: 1
Proposals on separate counting of votes for small and medium investors: all proposals
Proposals involving related shareholders’ avoidance of voting: None
Name of related shareholders who should avoid voting: None
- Proposals involving preference shareholders’ participation in voting: None
3. Things to note when voting at the shareholders’ meeting
(1) The shareholders of the Company who exercise their voting rights through the Shanghai Stock Exchange Shareholders Meeting online voting system can either log in to the trading system voting platform (through the trading terminal of the securities company designated for trading) to vote, or log in to the Internet voting platform (website: vote.sseinfo.com) to vote. When logging into the Internet voting platform to vote for the first time, investors need to complete shareholder identity authentication. For specific operations, please see the instructions on the Internet voting platform website.
(2) If the same voting right is voted on repeatedly through on-site, online voting platform of the Exchange or other methods, the result of the first vote shall prevail.
(3) For a shareholder holding multiple shareholder accounts, the number of exercisable voting rights is the total number of common shares of the same category and preference shares of the same variety held by all shareholder accounts under his or her name.
Shareholders holding multiple shareholder accounts who participate in online voting at the shareholders' meeting through the Exchange's online voting system can participate through any of their shareholder accounts. After the voting, it shall be deemed that all ordinary shares of the same category and preferred shares of the same variety under all shareholder accounts have voted with the same opinion.
If a shareholder holding multiple shareholder accounts votes repeatedly through multiple shareholder accounts, the voting opinions of the same class of ordinary shares and the same type of preferred stocks under all shareholder accounts shall be based on the first voting results of each class and type of stocks respectively.
(4) Shareholders must vote on all proposals before they can be submitted.
4. Participants at the meeting
(1) Shareholders of the company who are registered in the Shanghai Branch of China Securities Depository and Clearing Co., Ltd. at the close of the market in the afternoon on the equity registration day have the right to attend the shareholders’ meeting (see the table below for details), and may entrust a proxy in writing to attend the meeting and participate in voting. The agent does not have to be a shareholder of the company.
Share class Stock code Stock abbreviation Equity registration date
A shares 600513 Lianhuan Pharmaceutical 2026/9/17
(2) Directors and senior managers of the company.
(3) Lawyers hired by the company.
(4) Other personnel
5. Meeting registration method
(1) Registration time: 9:00 to 11:30 am on September 22, 2026.
(2) Registration location: Securities Department of Lianhuan Pharmaceutical, No. 9 Kangkang 1st Road, Yangzhou Bio-Health Industrial Park, Yangzhou City, Jiangsu Province.
(3) Individual shareholders attending the meeting must present their ID cards, Shanghai Stock Exchange stock account cards and shareholding certificates; entrusted agents must present their ID cards, power of attorney, Shanghai Stock Exchange stock account cards and shareholding certificates to register; corporate shareholders attending the meeting whose legal representatives are required to present their ID cards, copies of business licenses, legal representative qualification documents and shareholding certificates; entrusted agents must present their ID cards, copies of business licenses, legal representatives' power of attorney and shareholding certificates to register. Please see Appendix 1 for a sample of the power of attorney.
6. Other matters
(1) The meeting is expected to last half a day, and participating shareholders will be responsible for their own food, accommodation and transportation expenses.
(2) Contact information:
Correspondence address: No. 9, Jianjian 1st Road, Yangzhou Bio-Health Industrial Park, Yangzhou City, Jiangsu Province Postcode: 225127
Phone number: 0514-87813082
Fax number: 0514-87815079
Contact person: Corporate Securities Department
Announcement is hereby made.
Board of Directors of Jiangsu Lianhuan Pharmaceutical Co., Ltd.
August 29, 2026
Attachment 1: Power of attorney
Documents to be filed: "Resolution of the 28th Extraordinary Meeting of the Ninth Board of Directors of Lianhuan Pharmaceutical" Attachment 1: Power of Attorney
Power of attorney
Jiangsu Lianhuan Pharmaceutical Co., Ltd.:
I hereby authorize Mr. (Ms.) to represent the company (or myself) at the 2026 second extraordinary shareholders meeting of your company to be held on September 22, 2026, and to exercise voting rights on my behalf. Number of common shares held by the client:
Number of preferred shares held by the client:
Client shareholder account number:
Serial number Name of non-cumulative voting motion Agree Oppose Abstain "Shareholders of Lianhuan Pharmaceutical in the next three years (2026-2028)
Proposal on Dividend Return Planning"
Signature (stamped) of the principal: Signature of the trustee:
Trustee’s ID number: Trustee’s ID number:
Commission date: year month day
Remarks:
The client should choose one of the "agree", "objection" or "abstain" intentions in the power of attorney and tick "√". If the client does not give specific instructions in this power of attorney, the trustee has the right to vote according to his own wishes.